Kintor Pharma News Today : Breaking News, Live Updates & Top

Acne Vulgaris Market to Register Sustainable Growth by 2034, Examines DelveInsight | Key Companies - Dermata Therapeutics, AstraZeneca, Novartis Pharmaceuticals, UCB Pharma, Incyte Corporation

Published: May 27, 2024

/PRNewswire/ -- DelveInsight's Acne Vulgaris Market Insights report includes a comprehensive understanding of current treatment practices, acne vulgaris...

Source: prnewswire.com

Propulsion of Acne Vulgaris Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight

Published: September 1, 2023

(Albany, United States) As per DelveInsight’s assessment, globally, the Acne Vulgaris Pipeline constitutes 22+ key companies continuously working towards developing 22+ Acne Vulgaris Pipeline treatment therapies,

Source: benzinga.com

Kintor Pharmaceutical : Pharma Announces 2023 Interim Results and Recent Business Highlights -Today at 09:01 am

Published: August 28, 2023

Suzhou, August 28, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced its 2023...

Source: marketscreener.com

Kintor Pharmaceutical : Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China -Today at 04:54 am

Published: August 22, 2023

Suzhou, August 22, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company...

Source: marketscreener.com

Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China